Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neuberg Digipath is a healthcare diagnostics and digital pathology venture launched by Neuberg Diagnostics in partnership with OptraSCAN to provide digital pathology and telepathology services. The business focuses on digitization of tissue slides, storage and archiving, slide review and discussion workflows, digital learning modules, automated slide processing, and second-opinion teleconsulting for pathology. Its offering combines Neuberg's histopathology and cytology service capabilities with OptraSCAN's digital pathology imaging and cloud-ready workflow technology. The company appears to operate commercially as a digital pathology services and platform business rather than as a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neuberg Digipath.